JPS565414A - Chrome acetylacetonate as nutrition strengthener and medicine - Google Patents

Chrome acetylacetonate as nutrition strengthener and medicine

Info

Publication number
JPS565414A
JPS565414A JP3569380A JP3569380A JPS565414A JP S565414 A JPS565414 A JP S565414A JP 3569380 A JP3569380 A JP 3569380A JP 3569380 A JP3569380 A JP 3569380A JP S565414 A JPS565414 A JP S565414A
Authority
JP
Japan
Prior art keywords
acetylacetonate
strengthener
chrome
nutrition
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3569380A
Other languages
English (en)
Inventor
Patoritsuku Rairii Denisu
Moogan Andaason Maaku
Toruuman Rotoratsuku Jiyon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPS565414A publication Critical patent/JPS565414A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/30Oligoelements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • A23L33/165Complexes or chelates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/92Ketonic chelates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
JP3569380A 1979-03-19 1980-03-19 Chrome acetylacetonate as nutrition strengthener and medicine Pending JPS565414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2138279A 1979-03-19 1979-03-19

Publications (1)

Publication Number Publication Date
JPS565414A true JPS565414A (en) 1981-01-20

Family

ID=21803870

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3569380A Pending JPS565414A (en) 1979-03-19 1980-03-19 Chrome acetylacetonate as nutrition strengthener and medicine

Country Status (10)

Country Link
US (1) US4571391A (ja)
EP (1) EP0016496B1 (ja)
JP (1) JPS565414A (ja)
AT (1) ATE5049T1 (ja)
AU (1) AU536196B2 (ja)
CA (1) CA1154672A (ja)
DE (1) DE3065342D1 (ja)
IE (1) IE49650B1 (ja)
NZ (1) NZ193164A (ja)
ZA (1) ZA801555B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
JP2014506932A (ja) * 2011-03-01 2014-03-20 ジェーディーエス セラピューティックス、エルエルシー 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6831881A (en) * 1980-03-31 1981-10-08 Procter & Gamble Company, The Chromium complexes as dietary supplements and pharmaceutical agents
DE3334516A1 (de) * 1983-09-23 1985-04-11 Siemens AG, 1000 Berlin und 8000 München Koppelfeld mit verbindungswegeumkehr, insbesondere fuer fernsprechvermittlungsanlagen
DE3783206T2 (de) * 1986-10-27 1993-05-27 Abbott Lab Fluessige naehrwert-tabelle fuer glukose-intoleranz.
IL95220A0 (en) * 1989-07-28 1991-06-10 Thymax Corp Dithiochrome,an insulinbinding molecule,pharmaceutical compositions containing it and methods for extracting it
US5420108A (en) * 1992-09-14 1995-05-30 Shohet; Isaac H. Method of controlling diabetes mellitus
US5811463A (en) * 1993-10-06 1998-09-22 University Of British Columbia Compositions and method for relaxing smooth muscles
US5631284A (en) * 1993-10-06 1997-05-20 University Of British Columbia Compositions and methods for relaxing smooth muscles
US20050214384A1 (en) * 2002-04-23 2005-09-29 Vijaya Juturu Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
US7247328B2 (en) * 2002-05-31 2007-07-24 Zinpro Corporation Chromium (III) alpha amino acid complexes
US20060029642A1 (en) * 2004-08-03 2006-02-09 Dusan Miljkovic Methods and compositions for improved chromium complexes
US20060083824A1 (en) * 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
CA2931881C (en) * 2007-01-31 2018-12-11 Nutrition 21, Inc. Use of chromium histidinate for treatment of cardiometabolic disorders
CA2681158C (en) 2007-03-13 2018-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
US9585898B2 (en) 2008-02-11 2017-03-07 Kenneth O. Russell Method for the reduction of dangerous blood sugar levels
US8932372B2 (en) 2010-02-02 2015-01-13 Celanese International Corporation Integrated process for producing alcohols from a mixed acid feed
US11865121B2 (en) 2016-02-11 2024-01-09 Nutrition21, LLC Chromium containing compositions for improving health and fitness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134797A (en) * 1960-06-13 1964-05-26 Diamond Alkali Co Preparation of chromium complexes of beta-diketones
US3914410A (en) * 1972-06-13 1975-10-21 Bristol Myers Co Method for preparing sucrose composition containing chromium III salt
US3925433A (en) * 1973-09-10 1975-12-09 Zinpro Corp 1:1 And 2:1 chromium, alpha amino acid complex salts

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5991861A (ja) * 1982-11-17 1984-05-26 Bikou:Kk 栄養補助食品カルシウム粒
JP2014506932A (ja) * 2011-03-01 2014-03-20 ジェーディーエス セラピューティックス、エルエルシー 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物

Also Published As

Publication number Publication date
IE800547L (en) 1980-09-19
IE49650B1 (en) 1985-11-13
CA1154672A (en) 1983-10-04
AU5650280A (en) 1980-09-25
US4571391A (en) 1986-02-18
EP0016496A1 (en) 1980-10-01
AU536196B2 (en) 1984-04-19
EP0016496B1 (en) 1983-10-19
ZA801555B (en) 1981-04-29
DE3065342D1 (en) 1983-11-24
NZ193164A (en) 1984-12-14
ATE5049T1 (de) 1983-11-15

Similar Documents

Publication Publication Date Title
JPS565414A (en) Chrome acetylacetonate as nutrition strengthener and medicine
IL82209A0 (en) Insulin preparation
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
GEP20053538B (en) Pharmaceutical Composition Comprising A Combination of Metformin and Glyburide
ATE84414T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eines arneimittels zur behandlung von komplikationen bei diabetes mellitus.
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
AU520686B2 (en) 3, 4, 5-trihydroxypiperidines amd their use in animal nutrition and against diabetes
EP0342795A3 (en) Use of docosahexaenic acid for improving brain function
HU896546D0 (en) Transdermally usable medical preparations containing gestoden
ATE50493T1 (de) Ibuprofen enthaltendes arzneimittel.
HU910979D0 (en) Process for the prodiction of medical preparations with n-neuropeptide-antagonistic effect, containing guanidine derivatives
ES8602774A1 (es) Un procedimiento para producir un preparado farmaceutico percutaneo para uso externo
EP0347781A3 (en) Mini-proinsulin, its oroduction and use
CA2196174A1 (en) Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes
EP0019403A3 (en) Hydroxyalkyl-starch drug carrier and method of administering a biologically active compound to an animal
CA2113856A1 (en) Antidiabetic Agent
KR890004690A (ko) 당뇨병의 치료를 위한 베자피브레이드의 용도
EP0037144A3 (en) Chromium complexes as dietary supplements and pharmaceutical agents
ZA919938B (en) Short peptides with insulin activity
FR2390165A1 (fr) Nouveau medicament du type derive de glybutamide et compositions pharmaceutiques en contenant
Gilioli Neuro-and psychotropic effects of industrial chemicals and performance-affecting drugs (human studies). A review of papers presented at the Workshop of PC-IAOH Sub-Committee on Higher Nervous Functions, Prague, July 1975
Anialdi et al. Drug Toxicity and the Cardiovascular System in Paediatric Patients.
IL94241A0 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
Kitamoto Social Needs and Medical Society
ES1018016U (es) Jeringa para la inyeccion de productos, aplicable particularmente a veterinaria.